Authors

Latest:

Latest:

Allison Truong, M.D., FAAD, provides some useful tips to help health care professionals on the frontlines of the COVID-19 pandemic combat mask irritation and acne.

Latest:

In this follow up to last month’s Innovations column on intellectual property and technology transfer, Raymond A. Miller, J.D., and Steve Xu, M.D., FAAD discuss how to utilize patents to maximize value for your venture.

Latest:

In this pipeline report, Dermatology Times presents insights into Hh pathway inhibitors currently in phase 2 and phase 3 for the treatment of basal cell carcinoma. 

Latest:

Audits can be an unfortunate reality of practicing medicine. This expert explains the four main types of audits and offers tips to minimize audit stress.

Latest:

Recognizing the role of stress in skin disease can allow dermatologists to empower their patients to pursue any and all avenues for managing their disease.

Latest:

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Latest:

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Latest:

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Latest:

Lawrence Chukwudi Nwabudike, M.D., MBBS, MRCP (U.K.), PhD delves into what dermatologists need to know about homeopathy.

Latest:

Zoe Diana Draelos, M.D, discusses prebiotic, probiotic and postbiotic skincare products and their role in normalizing the skin microbiome.

Latest:

Determine whether a laser device is a good investment for a specific practice and, if so, how to choose the right piece of equipment.

Latest:

Joel Cohen, M.D., shares his response to recent findings regarding the safety of chemical sunscreen and discusses why patients should consider using physical sunscreens.

Latest:

Dean Celia, our original managing editor, reflects the beginning of Dermatology Times and the medical editors, Dr. Ronald Wheeland and Dr. Norman Levine,  who ensured the publication focused on the key industry developments that mattered most to practicing dermatologists.

Latest:

James Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Latest:

Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.

Latest:

Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.

Latest:

Researchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.

Latest:

In this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it. ƒ

Latest:

Drs. López and Kaufman discuss two new studies that examine the use of ultrasound technology as a new modality for treatment of erythematotelangiectatic and refractory rosacea.

Latest:

Harold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.

Latest:

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Latest:

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Latest:

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Latest:

Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.

Latest:

Todd Petersen, CEO of VitalSkin Dermatology, discusses the last part of your transition journey – ensuring a smooth, successful transition for you, your team and your patients.

Latest:

Carol Soutor, M.D., writes about efficacy and safety of mind-body therapies for the treatment of various skin conditions. 

Latest:

Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.

Latest:

Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.